Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. uri icon

Overview

publication date

  • December 7, 2021

Identity

PubMed Central ID

  • PMC8650200

Scopus Document Identifier

  • 85120503527

Digital Object Identifier (DOI)

  • 10.1016/j.cmet.2021.10.014

PubMed ID

  • 34879241

Additional Document Info

volume

  • 33

issue

  • 12